Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06399263
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-06
First Post:
2024-04-30
Brief Title:
Study of Psilocybin for Anorexia in Young Adults
Sponsor:
Marissa Raymond-Flesch MD MPH
Organization:
University of California San Francisco
Study Overview
Official Title:
Study of Psilocybin for Anorexia in Young Adults
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SPANYA
Brief Summary:
This is a single site trial of psilocybin therapy for the treatment of refractory Anorexia Nervosa in young adults The psilocybin therapy will include three preparatory sessions psilocybin dosing session one 20mg two integration sessions psilocybin dosing session two 30mg and four final integration sessions Eating disorder symptoms will be measured pre and post treatment Two family members of each young adult participant will be enrolled in the study One of which will be required to attend a portion of two preparatory sessions and a portion of two integration sessions and receive psychoeducation about supporting the young adult participant through preparation and integration for psilocybin therapy Investigators hypothesize that psilocybin will increase cognitive flexibility and that this increase will predict long-term changes in cognitive rigidity habitual eating and exercise behaviors in patients with Anorexia Nervosa
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None